Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effect of valsartan and perindopril on HOMA-IR Index in patients with chronic kidney disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese PLA General Hospital
• Treatments: Perindopril; Valsartan

Criteria

Inclusion Criteria:

• Clinical diagnosis of chronic kidney disease

• Serum creatinine:1~3mg/dl

Exclusion Criteria:

• Diabetes

• Patients treated with corticosteroids or immunosuppressants

• BMI>30kg/m2

• SP>180mmHg, DP>110mmHg

• Patients with serious medical problems requiring specific medical treatment